Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Integrator complex subunit 6 pseudogene 1 (INTS6P1) is a long non-coding RNA pseudogene closely homologous to the protein-coding INTS6 gene, sharing high sequence similarity. INTS6P1 does not encode a protein but functions as a competitive endogenous RNA within gene regulatory networks. It is tightly linked to tumor suppression in hepatocellular carcinoma, where it regulates the expression of INTS6 by competitively binding the oncogenic microRNA miR-17-5p. Experimental data indicate it is significantly downregulated in HCC and is being explored as a plasma-based biomarker for early detection of liver cancer. There are no known therapeutic drugs targeting INTS6P1, and it is functionally classified as a pseudogene and biomarker rather than a conventional receptor, enzyme, or drug target.
Not applicable for drugs, but as a ceRNA, INTS6P1 modulates gene expression by competitively binding miR-17-5p, which in turn regulates the functional INTS6 gene
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrator complex subunit 6 pseudogene 1 (INTS6P1).